Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.34 |
| ▸ | MYLK | Q15746 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | PRKCG | P05129 | 1/20 | 0.34 |
| ▸ | PRKCA | P17252 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31063157 | 0.88 | MEN1 (0.32) | PTPN1CA2LMNAMEN1KMT2A | |
| SCHEMBL31063377 | 0.86 | HSD17B10 (0.36) | PTPN1MEN1KMT2AMAPTPRKCE | |
| SCHEMBL5936401 | 0.83 | PTPN1 (0.39) | PTPN1CA2LMNATP53MEN1 | |
| SCHEMBL4799519 | 0.83 | PTPN1 (0.41) | PTPN1CA2LMNATP53MAPT | |
| SCHEMBL15335397 | 0.81 | PTPN1 (0.31) | PTPN1MAPTALDH1A1TDP1 | |
| SCHEMBL4799391 | 0.81 | PYCR1 (0.43) | LMNAMEN1KMT2AMAPTPRKCE | |
| SCHEMBL31063531 | 0.81 | SLC6A4 (0.46) | CA2 | |
| SCHEMBL4965724 | 0.80 | LMNA (0.40) | PTPN1CA2LMNATP53MEN1 | |
| SCHEMBL21362566 | 0.79 | L3MBTL1 (0.41) | LMNAMEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL6603605 | 0.79 | APLNR (0.44) | CA2MAOBIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170066754-A1 | ANTIVIRAL AGENT | SHIONOGI & CO., LTD. (JP) | 2017-03-09 | — | — | US | disclosed |
| US-9572813-B2 | Antiviral agent | SHIONOGI & CO., LTD. (JP) | 2017-02-21 | — | — | US | disclosed |
| US-20150202208-A1 | ANTIVIRAL AGENT | SHIONOGI & CO., LTD. (JP) | 2015-07-23 | — | — | US | disclosed |
| EP-1422218-B1 | ANTIVIRAL AGENT | SHIONOGI & CO (JP) | 2012-03-21 | — | — | EP | disclosed |
| EP-0975710-B2 | POLYMER ELECTROLUMINESCENT DEVICE | MERCK PATENT GMBH (DE) | 2009-06-10 | — | — | EP | disclosed |
| EP-0975710-B1 | POLYMER ELECTROLUMINESCENT DEVICE | KONINKL PHILIPS ELECTRONICS NV (NL) | 2003-09-10 | — | — | EP | disclosed |
| EP-1310540-A1 | Polymer electroluminescent device | Koninklijke Philips Electronics N.V. (NL) | 2003-05-14 | — | — | EP | disclosed |
| US-20020001732-A1 | POLYMER ELECTROLUMINESCENT DEVICE | U.S. PHILIPS CORPORATION | 2002-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150202208-A1 | ANTIVIRAL AGENT | ZC3HAV1, ZC3HAV1L, CCNI | PTPN1 3025/4885CA2 4439/4885LMNA 2945/4885 |
| US-20170066754-A1 | ANTIVIRAL AGENT | ZC3HAV1, ZC3HAV1L, CCNI | PTPN1 3025/4885CA2 4439/4885LMNA 2945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.